Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mauricio M Rodrigues

Showing results (41-50 of 66) with videos related to

Pageof 7
Sort By:
Plos Neglected Tropical Diseases|October 8, 2013
NLRP3 controls Trypanosoma cruzi infection through a caspase-1-dependent IL-1R-independent NO productionVirginia M Gonçalves, Kely C Matteucci, Carina L Buzzo, et al.
Frontiers in Immunology|May 14, 2014
Cross-Protective Immunity to Leishmania amazonensis is Mediated by CD4+ and CD8+ Epitopes of Leishmania donovani Nucleoside Hydrolase Terminal DomainsDirlei Nico, Daniele Crespo Gomes, Marcus Vinícius Alves-Silva, et al.
Parasites & Vectors|November 16, 2016
A recombinant multi-antigen vaccine formulation containing Babesia bovis merozoite surface antigens MSA-2a<sub>1</sub>, MSA-2b and MSA-2c elicits invasion-inhibitory antibodies and IFN-γ producing cellsAlba Marina Gimenez, Katia S Françoso, Jonatan Ersching, et al.
Expert Review of Vaccines|July 31, 2008
FML vaccine against canine visceral leishmaniasis: from second-generation to synthetic vaccineClarisa B Palatnik-de-Sousa, André de Figueiredo Barbosa, Sandra Maria Oliveira, et al.
Plos One|July 23, 2011
Subdominant/cryptic CD8 T cell epitopes contribute to resistance against experimental infection with a human protozoan parasiteMariana R Dominguez, Eduardo L V Silveira, José Ronnie C de Vasconcelos, et al.
Infection and Immunity|March 2, 2011
Heterologous plasmid DNA prime-recombinant human adenovirus 5 boost vaccination generates a stable pool of protective long-lived CD8(+) T effector memory cells specific for a human parasite, Trypanosoma cruziPaula Ordonhez Rigato, Bruna C de Alencar, José Ronnie C de Vasconcelos, et al.
Human Gene Therapy|September 9, 2004
Protective immunity against trypanosoma cruzi infection in a highly susceptible mouse strain after vaccination with genes encoding the amastigote surface protein-2 and trans-sialidaseJosé Ronnie Vasconcelos, Meire I Hiyane, Cláudio R F Marinho, et al.
Human Gene Therapy|February 27, 2014
Adenovirus vector-induced CD8⁺ T effector memory cell differentiation and recirculation, but not proliferation, are important for protective immunity against experimental Trypanosoma cruzi InfectionJosé Ronnie Vasconcelos, Mariana R Dominguez, Ramon L Neves, et al.
Transplant Immunology|February 24, 2009
A role for regulatory T cells in renal acute kidney injuryRebecca M M Monteiro, Niels O S Camara, Mauricio M Rodrigues, et al.
Infection and Immunity|August 5, 2009
Perforin and gamma interferon expression are required for CD4+ and CD8+ T-cell-dependent protective immunity against a human parasite, Trypanosoma cruzi, elicited by heterologous plasmid DNA prime-recombinant adenovirus 5 boost vaccinationBruna C G de Alencar, Pedro M Persechini, Filipe A Haolla, et al.
Pageof 7

Showing results (41-50 of 66) with videos related to

Sort By:
Pageof 7
Plos Neglected Tropical Diseases|October 8, 2013
NLRP3 controls Trypanosoma cruzi infection through a caspase-1-dependent IL-1R-independent NO productionVirginia M Gonçalves, Kely C Matteucci, Carina L Buzzo, et al.
Frontiers in Immunology|May 14, 2014
Cross-Protective Immunity to Leishmania amazonensis is Mediated by CD4+ and CD8+ Epitopes of Leishmania donovani Nucleoside Hydrolase Terminal DomainsDirlei Nico, Daniele Crespo Gomes, Marcus Vinícius Alves-Silva, et al.
Parasites & Vectors|November 16, 2016
A recombinant multi-antigen vaccine formulation containing Babesia bovis merozoite surface antigens MSA-2a<sub>1</sub>, MSA-2b and MSA-2c elicits invasion-inhibitory antibodies and IFN-γ producing cellsAlba Marina Gimenez, Katia S Françoso, Jonatan Ersching, et al.
Expert Review of Vaccines|July 31, 2008
FML vaccine against canine visceral leishmaniasis: from second-generation to synthetic vaccineClarisa B Palatnik-de-Sousa, André de Figueiredo Barbosa, Sandra Maria Oliveira, et al.
Plos One|July 23, 2011
Subdominant/cryptic CD8 T cell epitopes contribute to resistance against experimental infection with a human protozoan parasiteMariana R Dominguez, Eduardo L V Silveira, José Ronnie C de Vasconcelos, et al.
Infection and Immunity|March 2, 2011
Heterologous plasmid DNA prime-recombinant human adenovirus 5 boost vaccination generates a stable pool of protective long-lived CD8(+) T effector memory cells specific for a human parasite, Trypanosoma cruziPaula Ordonhez Rigato, Bruna C de Alencar, José Ronnie C de Vasconcelos, et al.
Human Gene Therapy|September 9, 2004
Protective immunity against trypanosoma cruzi infection in a highly susceptible mouse strain after vaccination with genes encoding the amastigote surface protein-2 and trans-sialidaseJosé Ronnie Vasconcelos, Meire I Hiyane, Cláudio R F Marinho, et al.
Human Gene Therapy|February 27, 2014
Adenovirus vector-induced CD8⁺ T effector memory cell differentiation and recirculation, but not proliferation, are important for protective immunity against experimental Trypanosoma cruzi InfectionJosé Ronnie Vasconcelos, Mariana R Dominguez, Ramon L Neves, et al.
Transplant Immunology|February 24, 2009
A role for regulatory T cells in renal acute kidney injuryRebecca M M Monteiro, Niels O S Camara, Mauricio M Rodrigues, et al.
Infection and Immunity|August 5, 2009
Perforin and gamma interferon expression are required for CD4+ and CD8+ T-cell-dependent protective immunity against a human parasite, Trypanosoma cruzi, elicited by heterologous plasmid DNA prime-recombinant adenovirus 5 boost vaccinationBruna C G de Alencar, Pedro M Persechini, Filipe A Haolla, et al.
Pageof 7